Update on the changing epidemiology of Clostridium difficile-associated disease (original) (raw)

• Berrington A et al. (2004) National Clostridium difficile standards group: report to the Department of Health. J Hosp Infect 56: 1–38
  Google Scholar
• McFarland LV et al. (2007) Implications of the changing face of Clostridium difficile disease for health care practitioners. Am J Infect Control 35: 237–253
  Article Google Scholar
• Cloud J and Kelly CP (2007) Update on Clostridium difficile associated disease. Curr Opin Gastroenterol 23: 4–9
  PubMed Google Scholar
• McDonald LC et al. (2005) An epidemic, toxin gene–variant strain of Clostridium difficile. N Engl J Med 353: 2433–2441
  Article CAS Google Scholar
• McDonald LC et al. (2006) Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996–2003. Emerg Infect Dis 12: 409–415
  Article Google Scholar
• Loo VG et al. (2005) A predominantly clonal multi-institutional outbreak of _Clostridium-difficile_-associated diarrhea with high morbidity and mortality. N Engl J Med 353: 2442–2449
  Article CAS Google Scholar
• McFarland LV et al. (1989) Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 320: 204–210
  Article CAS Google Scholar
• McMaster-Baxter NL and Musher DM (2007) Clostridium difficile: recent epidemiologic findings and advances in therapy. Pharmacotherapy 27: 1029–1039
  Article CAS Google Scholar
• Rupnik M et al. (2005) Revised nomenclature of Clostridium difficile toxins and associated genes. J Med Microbiol 54: 113–117
  Article CAS Google Scholar
• Geric B et al. (2004) Distribution of Clostridium difficile variant toxinotypes and strains with binary toxin genes among clinical isolates in an American hospital. J Med Microbiol 53: 887–894
  Article CAS Google Scholar
• Goncalves C et al. (2004) Prevalence and characterization of a binary toxin (actin-specific ADP-ribosyltransferase) from Clostridium difficile. J Clin Microbiol 42: 1933–1939
  Article CAS Google Scholar
• McDonald LC et al.; Ad Hoc Clostridium difficile Surveillance Working Group. Recommendations for surveillance of _Clostridium difficile_-associated disease. Infect Control Hosp Epidemiol 28: 140–145
• Rupnik M et al. (2003) New types of toxin A-negative, toxin B-positive strains among Clostridium difficile isolates from Asia. J Clin Microbiol 41: 1118–1125
  Article CAS Google Scholar
• Delmee M et al. (2005) Laboratory diagnosis of _Clostridium difficile_-associated diarrhoea: a plea for culture. J Med Microbiol 54: 187–191
  Article CAS Google Scholar
• Gerding DN (2007) New definitions will help, but cultures are critical for resolving unanswered questions about Clostridium difficile. Infect Control Hosp Epidemiol 28: 113–115
  Article Google Scholar
• Cookson B (2007) Hypervirulent strains of Clostridium difficile. Postgrad Med J 83: 291–295
  Article Google Scholar
• Pepin J et al. (2004) _Clostridium difficile_-associated diarrhea in a region of Québec from 1991 to 2003: a changing pattern of disease severity. CMAJ 171: 466–472
  Article Google Scholar
• Pepin J et al. (2005) Mortality attributable to nosocomial _Clostridium difficile_-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ 173: 1037–1042
  Article Google Scholar
• MacCannell DR et al. (2006) Molecular analysis of Clostridium difficile PCR ribotype 027 isolates from Eastern and Western Canada. J Clin Microbiol 44: 2147–2152
  Article CAS Google Scholar
• Warny M et al. (2005) Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366: 1079–1084
  Article CAS Google Scholar
• Kuijper EJ et al. (2007) Clostridium difficile: changing epidemiology and new treatment options. Curr Opin Infect Dis 20: 376–383
  PubMed Google Scholar
• Hubert B et al. (2007) A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of _C. difficile_-associated disease in Québec. Clin Infect Dis 44: 238–244
  Article CAS Google Scholar
• Musher DM et al. (2006) Epidemic Clostridium difficile. N Engl J Med 354: 1199–1203
  Article CAS Google Scholar
• Kuijper EJ et al. (2007) Update of _Clostridium difficile_-associated disease due to PCR ribotype 027 in Europe. Euro Surveill 12: E1–E2
  Article CAS Google Scholar
• van Steenbergen J et al. (2005) Isolation of Clostridium difficile ribotype 027, toxinotype III in the Netherlands after increase in C. _difficile_-associated diarrhoea. Euro Surveill 10: E050714.1
  PubMed Google Scholar
• Kuijper EJ et al.; ESCMID Study Group for Clostridium difficile; EU Member States; European Centre for Disease Prevention and Control (2006) Emergence of _Clostridium difficile_-associated disease in North America and Europe. Clin Microbiol Infect 12 (Suppl 6): S2–S18
  Article Google Scholar
• Delmee M et al. (2006) Epidemiology of Clostridium difficile toxinotype III, PCR-ribotype 027 associated disease in Belgium, 2006. Euro Surveill 11: E060914.2
  CAS PubMed Google Scholar
• Kato H et al. (2007) First isolation of Clostridium difficile 027 in Japan. Euro Surveill 12: E070111.3
• Tachon M et al. (2006) First cluster of C. difficile toxinotype III, PCR-ribotype 027 associated disease in France: preliminary report. Euro Surveill 11: E060504.1
  CAS PubMed Google Scholar
• Biller P et al. (2007) Moxifloxacin therapy as a risk factor for Clostridium difficile –associated disease during an outbreak: attempts to control a new epidemic strain. Infect Control Hosp Epidemiol 28: 198–201
  Article Google Scholar
• Coignard B et al. (2006) Emergence of Clostridium difficile toxinotype III, PCR-ribotype 027-associated disease, France, 2006. Euro Surveill 11: E060914.1
  CAS PubMed Google Scholar
• Kazakova SV et al. (2006) A hospital outbreak of diarrhea due to an emerging epidemic strain of Clostridium difficile. Arch Intern Med 166: 2518–2524
  Article Google Scholar
• Rodriguez-Palacios A et al. (2006) Clostridium difficile PCR ribotypes in calves, Canada. Emerg Infect Dis 12: 1730–1736
  Article CAS Google Scholar
• Drudy D et al. (2007) Emergence and control of fluoroquinolone-resistant, toxin A-negative, toxin B-positive Clostridium difficile. Infect Control Hosp Epidemiol 28: 932–940
  Article Google Scholar
• McFarland LV et al. (2007) Fluoroquinolone use and risk factors for Clostridium difficile disease within a Veterans Administration Health Care System. Clin Infect Dis 45: 1141–1151
  Article Google Scholar
• Clabots CR et al. (1992) Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection. J Infect Dis 166: 561–567
  Article CAS Google Scholar
• Shim JK et al. (1998) Primary symptomless colonization by Clostridium difficile and decreased risk of subsequent diarrhoea. Lancet 351: 633–636
  Article CAS Google Scholar
• Terhes G et al. (2004) Community-acquired Clostridium difficile diarrhea caused by binary toxin, toxin A, and toxin B gene-positive isolates in Hungary. J Clin Microbiol 42: 4316–4318
  Article CAS Google Scholar
• Beaugerie L et al. (2003) Antibiotic-associated diarrhoea and Clostridium difficile in the community. Aliment Pharmacol Ther 17: 905–912
  Article CAS Google Scholar
• Centers for Disease Control (2005) Severe _Clostridium difficile_-associated disease in populations previously at low risk—four states, 2005. MMWR Morb Mortal Wkly Rep 54: 1201–1205
• Dial S et al. (2006) Proton pump inhibitor use and risk of community-acquired _Clostridium difficile_-associated disease defined by prescription for oral vancomycin therapy. CMAJ 175: 745–748
  Article Google Scholar
• Lefebvre SL et al. (2006) Prevalence of zoonotic agents in dogs visiting hospitalized people in Ontario: implications for infection control. J Hosp Infect 62: 458–466
  Article CAS Google Scholar
• Dial S et al. (2005) Use of gastric acid-suppressive agents and the risk of community-acquired _Clostridium difficile_-associated disease. JAMA 294: 2989–2995
  Article CAS Google Scholar
• Kyne L et al. (2001) Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhea. Lancet 357: 189–193
  Article CAS Google Scholar
• McFarland LV et al. (2000) Pediatric Clostridium difficile: a phantom menace or clinical reality. J Pediatr Gastroenterol Nutr 31: 220–231
  Article CAS Google Scholar
• Morinville V and McDonald J (2005) _Clostridium difficile_-associated diarrhea in 200 Canadian children. Can J Gastroenterol 19: 497–501
  Article Google Scholar
• Gogate A et al. (2005) Diagnostic role of stool culture & toxin detection in antibiotic associated diarrhoea due to Clostridium difficile in children. Indian J Med Res 122: 518–524
  CAS PubMed Google Scholar
• Gaynes R et al. (2004) Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use. Clin Infect Dis 38: 640–645
  Article Google Scholar
• Pepin J et al. (2005) Emergence of fluoroquinolones as the predominant risk factor for _Clostridium difficile_-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 41: 1254–1260
  Article CAS Google Scholar
• Johnson S et al. (1990) Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission. Am J Med 88: 137–140
  Article CAS Google Scholar
• Gerding et al. (1995) _Clostridium difficile_-associated diarrhea and colitis. Infect Control Hosp Epidemiol 16: 459–477
  Article CAS Google Scholar
• Boone N et al. (1998) Evaluation of an interdisciplinary re-isolation policy for patients with previous Clostridium difficile diarrhea. Amer J Infect. Control 26: 584–587
  Article CAS Google Scholar
• McMullen KM et al. (2007) Use of hypochlorite solution to decrease rates of _Clostridium difficile_-associated diarrhea. Infect Control Hosp Epidemiol 28: 205–207
  Article Google Scholar
• Sehulster L and Chinn RY (2003) Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 52: 1–42
  PubMed Google Scholar
• Jernigan JA et al. (1998) A randomized crossover study of disposable thermometers for prevention of Clostridium difficile and other nosocomial infections. Infect Control Hosp Epidemiol 19: 494–499
  Article CAS Google Scholar
• Davey P et al. (2005) Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database of Systemetic Reviews 2005, Issue 4. Art. No.: CD003543. doi:10.1002/14651858.CD003543.pub2
  Google Scholar
• Dellit TH et al.; Infectious Diseases Society of America; Society for Healthcare Epidemiology of America (2007) Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 44: 159–177
  Article Google Scholar
• Valiquette L et al. (2007) Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of _Clostridium difficile_-associated disease cause by the hypervirulent NAP1/027 Strain. Clin Infect Dis 45 (Suppl 2): S112–S121
  Article CAS Google Scholar
• Sunenshine RH and McDonald LC (2006) _Clostridium difficile_-associated disease: new challenges from an established pathogen. Cleveland Clinic J Med 73: 187–197
  Article Google Scholar
• Apisarnthanarak A et al. (2004) Effectiveness of environmental and infection control programs to reduce transmission of Clostridium difficile. Clin Infect Dis 39: 601–602
  Article Google Scholar
• Owens RC Jr and Rice L (2006) Hospital-based strategies for combating resistance. Clin Infect Dis 42 (Suppl 4): S173–S181
  Article CAS Google Scholar
• Zar FA et al. (2007) A comparison of vancomycin and metronidazole for the treatment of _Clostridium difficile_-associated diarrhea, stratified by disease severity. Clin Infect Dis 45: 302–307
  Article CAS Google Scholar
• McFarland LV et al. (2002) Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease. Am J Gastroenterol 97: 1769–1775
  Article CAS Google Scholar
• Teasley DG et al. (1983) Prospective randomised trial of metronidazole versus vancomycin for _Clostridium difficile_-associated diarrhoea and colitis. Lancet 2: 1043–1046
  Article CAS Google Scholar
• Wenisch C et al. (1996) Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of _Clostridium difficile_-associated diarrhea. Clin Infect Dis 22: 813–818
  Article CAS Google Scholar
• Pepin J et al. (2005) Increasing risk of relapse after treatment of Clostridium difficile colitis in Québec, Canada. Clin Infect Dis 40: 1591–1597
  Article CAS Google Scholar
• Musher D et al. (2005) Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole. Clin Infect Dis 40: 1586–1590
  Article CAS Google Scholar
• Lagrotteria D et al. (2006) Prospective, randomized inpatient study of oral metronidazole versus oral metronidazole and rifampin for treatment of primary episode of _Clostridium difficile_-associated diarrhea. Clin Infect Dis 43: 547–552
  Article CAS Google Scholar
• Pelaez T et al. (2002) Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin. Antimicrob Agents Chemother 46: 647–1650
  Google Scholar
• Louie TJ et al. (2006) Tolevamer, a novel nonantibiotic polymer, compared with vancomycin in the treatment of mild to moderately severe Clostridium difficile associated diarrhea. Clin Infect Dis 43: 411–420
  Article CAS Google Scholar
• Elmer GW et al. (2007) AAD and Clostridium difficile disease. In. The Power of Probiotics: Improving Your Health with Beneficial Microbes, 71–93 (Eds Elmer GE, McFarland LV, McFarland MJ) Binghamton, NY: Haworth Press
  Google Scholar
• Surawicz CM et al. (2000) The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. Clin Infect Dis 31: 1012–1017
  Article CAS Google Scholar
• McFarland LV et al. (2006) Meta-analysis of probiotics for prevention of antibiotic associated diarrhea and treatment of Clostridium difficile disease. Am J Gastroenterol 101: 812–822
  Article Google Scholar
• Mulligan ME et al. (1993) Electated levels of serum immunoglobulins in asymptomatic carriers of Clostridium difficile. Clin Infect Dis 16 (Suppl 4): S239–S244
  Article Google Scholar